Creatine kinase elevations after coronary interventions;Elevaciones de la creatincinasa tras intervencionismo coronario

Revista Espanola de Cardiologia

Volumn 54, Issue 3, 2001, Pages 282-288

  Jiménez Navarro, Manuel F ^a,b   Curiel, Emilio ^a   Alonso Briales, Juan H ^a   Hernández García, José María ^a   Cabrera, Fernando ^a   Gómez Doblas, José Juan ^a   Ruiz Del Fresno, Luis ^a   Pascual, Pedro ^a   Domínguez, Antonio ^a   Ruiz Ruiz, Manuel ^a   De Teresa, Eduardo ^a  

^a H Virgen de la Victoria   (Spain)

^b HOSPITAL UNIVERSITARIO VIRGEN DE LA VICTORIA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

CREATINE KINASE;

ARTICLE; BLOOD; FEMALE; HUMAN; INCIDENCE; MALE; MIDDLE AGED; POSTOPERATIVE COMPLICATION; TRANSLUMINAL CORONARY ANGIOPLASTY;

ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; CREATINE KINASE; FEMALE; HUMANS; INCIDENCE; MALE; MIDDLE AGED; POSTOPERATIVE COMPLICATIONS;

EID: 0035290920     PISSN: 03008932     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0300-8932(01)76309-9     Document Type: Article

References (24)

1. Unger F. Cardiac Interventions in Europe 1996: Open Heart Surgery and coronary revascularization. Report of the European Heart Institute of the European Academy of Sciences and Arts. Cor Europeaum 1998; 7: 81-83.
2. Soriano J, Alfonso F, Cequier A, Moris C. Registro de la actividad de la Sección de Hemodinámica y Cardiología Intervencionista del año 1997. Rev Esp Cardiol 1998; 51: 927-938.
3. Alonso J, Azpitarte J, Bardají A, Cabadés A, Fernández A, Palencia M et al. Guías de práctica clínica de la Sociedad Española de Cardiología en cirugía coronaria. Rev Esp Cardiol 2000; 53: 241-246.
4. Califf RM, Abdelmeguid AE, Kuntz RE, Popma JJ, Davidson CJ, Cohen EA et al. Myonecrosis after revascularization procedures. J Am Coll Cardiol 1998; 31: 241-251.
5. Klein LW, Kramer BL, Howard E, Lesch M. Incidence and clinical significance of transiet creatine kinase elevations and the diagnosis of non-q wave myocardial infarction associated with coronary angioplasty. J Am Coll Cardiol 1991; 17: 621-626.
6. The EPIC investigators. Use of a monoclonal antibody directed against the platelet glycoprotein IIb/IIIa receptor in high risk coronary angioplasty. N Engl J Med 1994; 330: 956-961.
7. Sitges M, Bosch X, Sanz G. Eficacia de los bloqueadores de los receptores plaquetarios IIb/IIIa en los síndromes coronarios agudos. Rev Esp Cardiol 2000; 53: 422-439.
8. López de Sá E. Identificación de los pacientes de alto riesgo en la evaluación inicial de la angina inestable. Importancia de la clínica, el electrocardiograma, el Holter y los marcadores bioquímicos de lesión miocárdica. Rev Esp Cardiol 1999; 52 (Supl 1): 97-106.
9. Kong TQ Jr, Davidson CJ, Meyers SN, Tauke JT, Parker MA, Bonow RO. Prognostic implication of creatine kinase elevation following elective coronary artery interventions. JAMA 1997; 227: 461-466.
10. Elliott JM, Berdan LG, Holmes DR, Isner JM, King SB, Keeler JP, for the CAVEAT Study Investigators. One year follow up in the coronary angioplasty versus excisional atherectomy trial (CAVEAT I). Circulation 1995; 91: 2158-2166.
11. Topol EJ, Ferguson JJ, Weisman HF, Tcheng JE, Ellis SG, Kleiman NS et al. Long-term protection from myocardial ischemic events in a randomized trial of brief integrin B3 blockade with percutaneous coronary intervention. JAMA 1997; 278: 479-484.
12. Mehta SR, Natarajan MK, Goodhart DM, Millencoff S, Kreatsoulas C, Yusuf S. Do peri-procedure creatine kinase elevations in Trials of percutaneous intervention reflect those observed in Clinical Practice? [resumen]. J Am Coll Cardiol 1999; 33 (Supl A): 23.
13. Lim R, Zawacki K, Laskey W. Creatine kinase release after catheter-based coronary intervention. Catheterization and cardiovascular diagnosis 1997; 41: 117-119.
14. Abdelmeguid AE, Topol EJ, Whitlow PL, Sapp SK, Ellis SG. Significance of mild transient release of creatine kinase-MB fraction after percutaneous coronary interventions. Circulation 1996; 94: 1528-1536.
15. Waksman R, Scott NA, Douglas JS, Mays R, Peterson J, King SB. Distal embolization is common after directional atherectomy in coronary arteries and vein grafts. Circulation 1993; 88 (Supl 1): 299.
16. Talasz H, Genser N, Mair J, Dworzak EA, Friedrich G, Moes N et al. Side branch occlusion during percutaneous trasluminal coronary angioplasty. Lancet 1992; 339: 1380-1382.
17. Bertinchant JP, Polge A, Ledermann B, Genet L, Fabbro-Peray P, Raczka F et al. Relation of minor cardiac troponin I elevation to late cardiac events after uncomplicated elective successful percutaneous trasluminal coronary angioplasty for angina pectoris. Am J Cardiol 1999; 84: 51-57.
18. Garbarz E, Lung B, Lefevre G, Makita Y, Farah B, Michaud P et al. Frecuency and prognostic value of cardiac troponin I elevation after coronary stenting. Am J Cardiol 1999; 84: 515-518.
19. Lindahl B, Venge P, Wallentin L. Relation between Troponin T and the risk of subsequent events in unstable coronary artery disease. Circulation 1996; 93: 1651-1657.
20. Shyu K, Kuan P, Cheng J, Hung C. Cardiac troponin T, creatine kinase, and its isoform release after successful percutaneous transluminal coronary angioplasty with or without stenting. Am Heart J 1998; 135: 862-867.
21. Van de Wert F. More evidence for a beneficial effect of platelet glycoprotein IIb/III a blockade during coronary interventions- latest results from EPILOG and CAPTURE trials. Eur Heart J 1996; 17: 325-326.
22. Hamm CW, Heeschen C, Goldmann B, Vahanian A, Adgey J, Macaya C et al. Benefit of abciximab in patients with refractory unstable angina in relation to serum troponin T levels. N Engl J Med 1999; 340: 1623-1629.
23. Laskey WK. Beneficial impact of preconditioning during PTCA on creatine kinase release. Circulation 1999; 99: 2085-2089.
24. Mehran R, Dangas G, Mintz GS, Lansky AJ, Pichard AD, Satler LF et al. Atherosclerotic plaque burden and CK-MB enzyme elevation after coronary interventions: intravascular ultrasound study of 2256 patients. Circulation 2000; 101: 604-610.